Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
single dose
|
| gptkbp:alternativeTo |
gptkb:Shingrix
|
| gptkbp:approvalYear |
2006
|
| gptkbp:approvedBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:ATCCode |
gptkb:J07BK02
|
| gptkbp:contains |
live attenuated varicella-zoster virus
|
| gptkbp:contraindication |
pregnant women
immunocompromised individuals |
| https://www.w3.org/2000/01/rdf-schema#label |
Zostavax
|
| gptkbp:indication |
adults aged 50 years and older
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
headache
allergic reactions injection site reactions |
| gptkbp:storage |
refrigerated (2–8°C)
|
| gptkbp:usedFor |
prevention of herpes zoster
prevention of shingles |
| gptkbp:withdrawn |
gptkb:Europe
2020 |
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|